Dennis Gillings
Dr. Gillings was born and educated in the United Kingdom. He began providing statistical consulting and data management services to pharmaceutical clients in 1974 during his tenure as Professor of Biostatistics at the University of North Carolina at Chapel Hill. Dr. Gillings founded Quintiles in 1982, which grew out of his consulting activitieswith the pharma industry. He took Quintiles public on NASDAQ in 1994 and led its privatization in 2003. Today, Quintiles is the largest global provider of clinical trials and commercial marketing services to the pharma and biotechnology industry.With more than 30 years of experience in drug development applications and theory, Dr. Gillings has provided expert consultation to numerous companies and health organizations, including the National Cancer Institute, the National Institute for Dental Research and the Institute of Medicine. He has served on several Advisory Boards and Councils including the Cambridge Judge Business School Advisory Board, the Scottish Enterprise Advisory Board and the International Advisory Council in Singapore. He also was the founding Chairman of the Association of Clinical Research Organizations, a Washington-based trade group formed in 2002.He served for more than 15 years as a professor at the University of North Carolina at Chapel Hill and received the Honorary Degree of Doctor of Science in May 2001. - See more at: http://www.quintiles.com/news/biographies/dennis-gillings/#sthash.wvTgIiu2.dpuf
Last updated:
For AI agents: llms.txt
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
How do I contact Dennis Gillings?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
